Vault-13

Frazier Life Sciences Management, L.P.

PALO ALTO, CA · CIK 1892134 · 13F filing filed 2023-05-15

SEC-registered investment adviser since 2021 · limited partnership

As an employer

Where they work

people there (dot area)number not reportedmain officeHover or tap a dot. Australian and UK companies are placed at their business or registered address, with their staff across the whole country.

Offices

From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.

CityCountryPeople
Palo Alto, CA (main office)United States United Statesabout 44
San Diego, CAUnited States United States3

Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.

$1.4bn reported value -14.1% vs Q4 2022
49positions
65.3%in top 10
8 new 7 added 4 reduced 3 sold out vs Q4 2022

Holdings, Q1 2023

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 HILLEVAX INC COM COM 9,781,472 $161.7m11.71% 11.71% AddedShares held: Q2 2022 9.3m, Q3 2022 9.8m, Q4 2022 9.8m, Q1 2023 9.8m +23.1k +23,113 0.2%
2 NEWAMSTERDAM PHARMA COMPANY ORDINARY SHARES NAMS NAMS 9,341,551 $125.6m9.09% 9.09% UnchangedShares held: Q2 2022 0, Q3 2022 0, Q4 2022 9.3m, Q1 2023 9.3m
3 CHINOOK THERAPEUTICS INC COM ADRO ADRO 4,345,559 $100.6m7.28% 7.28% UnchangedShares held: Q2 2022 3.6m, Q3 2022 4.3m, Q4 2022 4.3m, Q1 2023 4.3m
4 ARCUTIS BIOTHERAPEUTICS INC COM ARQT ARQT 8,684,232 $95.5m6.92% 6.92% UnchangedShares held: Q2 2022 8.4m, Q3 2022 8.7m, Q4 2022 8.7m, Q1 2023 8.7m
5 MIRUM PHARMACEUTICALS INC COM MIRM MIRM 3,860,107 $92.7m6.71% 6.71% UnchangedShares held: Q2 2022 3.6m, Q3 2022 3.8m, Q4 2022 3.9m, Q1 2023 3.9m
6 SYNDAX PHARMACEUTICALS INC COM SNDX SNDX 3,708,838 $78.3m5.67% 5.67% UnchangedShares held: Q2 2022 3.2m, Q3 2022 3.4m, Q4 2022 3.7m, Q1 2023 3.7m
7 KRYSTAL BIOTECH INC COM KRYS KRYS 945,407 $75.7m5.48% 5.48% ReducedShares held: Q2 2022 1.1m, Q3 2022 1.0m, Q4 2022 999.7k, Q1 2023 945.4k -54.3k -54,330 -5.4%
8 PHATHOM PHARMACEUTICALS INC COM PHAT PHAT 8,407,152 $60.0m4.35% 4.35% UnchangedShares held: Q2 2022 5.8m, Q3 2022 8.4m, Q4 2022 8.4m, Q1 2023 8.4m
9 VERONA PHARMA PLC SPONSORED ADS VRNA VRNA 2,944,349 $59.1m4.28% 4.28% AddedShares held: Q2 2022 0, Q3 2022 2.1m, Q4 2022 2.8m, Q1 2023 2.9m +128.6k +128,629 4.6%
10 VAXCYTE INC COM PCVX PCVX 1,397,405 $52.4m3.79% 3.79% UnchangedShares held: Q2 2022 1.8m, Q3 2022 1.5m, Q4 2022 1.4m, Q1 2023 1.4m
11 RHYTHM PHARMACEUTICALS INC COM RYTM RYTM 2,164,739 $38.6m2.80% 2.80% AddedShares held: Q2 2022 0, Q3 2022 1.9m, Q4 2022 1.9m, Q1 2023 2.2m +270.7k +270,739 14.3%
12 KALVISTA PHARMACEUTICALS INC COM KALV KALV 3,238,859 $25.5m1.84% 1.84% UnchangedShares held: Q2 2022 1.6m, Q3 2022 1.6m, Q4 2022 3.2m, Q1 2023 3.2m
13 COGENT BIOSCIENCES INC COM COGT COGT 2,159,154 $23.3m1.69% 1.69% AddedShares held: Q2 2022 2.1m, Q3 2022 2.1m, Q4 2022 2.1m, Q1 2023 2.2m +50.0k +50,000 2.4%
14 ALPINE IMMUNE SCIENCES INC COM NVLS NVLS 2,985,757 $23.1m1.67% 1.67% UnchangedShares held: Q2 2022 3.0m, Q3 2022 3.0m, Q4 2022 3.0m, Q1 2023 3.0m
15 TYRA BIOSCIENCES INC COM TYRA TYRA 1,421,310 $22.8m1.65% 1.65% AddedShares held: Q2 2022 1.4m, Q3 2022 1.3m, Q4 2022 1.3m, Q1 2023 1.4m +93.6k +93,645 7.0%
16 CRINETICS PHARMACEUTICALS IN COM CRNX CRNX 1,414,823 $22.7m1.65% 1.65% UnchangedShares held: Q2 2022 1.4m, Q3 2022 1.4m, Q4 2022 1.4m, Q1 2023 1.4m
17 TARSUS PHARMACEUTICALS INC COM TARS TARS 1,787,527 $22.5m1.63% 1.63% UnchangedShares held: Q2 2022 1.8m, Q3 2022 1.8m, Q4 2022 1.8m, Q1 2023 1.8m
18 THESEUS PHARMACEUTICALS INC COM COM 2,248,194 $20.0m1.45% 1.45% AddedShares held: Q2 2022 0, Q3 2022 0, Q4 2022 1.4m, Q1 2023 2.2m +850.0k +850,000 60.8%
19 ANAPTYSBIO INC COM ANAB ANAB 899,700 $19.6m1.42% 1.42% UnchangedShares held: Q2 2022 899.7k, Q3 2022 899.7k, Q4 2022 899.7k, Q1 2023 899.7k
20 BRIDGEBIO PHARMA INC COM BBIO BBIO 1,171,650 $19.4m1.41% 1.41% NewShares held: Q2 2022 0, Q3 2022 0, Q4 2022 0, Q1 2023 1.2m
21 REVOLUTION MEDICINES INC COM RVMD RVMD 854,484 $18.5m1.34% 1.34% NewShares held: Q2 2022 0, Q3 2022 0, Q4 2022 0, Q1 2023 854.5k
22 ENLIVEN THERAPEUTICS INC COM ELVN ELVN 830,983 $18.2m1.32% 1.32% NewShares held: Q2 2022 0, Q3 2022 0, Q4 2022 0, Q1 2023 831.0k
23 ACADIA PHARMACEUTICALS INC COM ACAD ACAD 857,338 $16.1m1.17% 1.17% UnchangedShares held: Q2 2022 0, Q3 2022 857.3k, Q4 2022 857.3k, Q1 2023 857.3k
24 GRITSTONE BIO INC COM GRTS GRTS 5,162,348 $14.4m1.04% 1.04% UnchangedShares held: Q2 2022 5.2m, Q3 2022 5.2m, Q4 2022 5.2m, Q1 2023 5.2m
25 MERUS N V COM MRUS MRUS 746,479 $13.7m0.99% 0.99% UnchangedShares held: Q2 2022 674.0k, Q3 2022 746.5k, Q4 2022 746.5k, Q1 2023 746.5k
26 TREVI THERAPEUTICS INC COM TRVI TRVI 6,663,590 $12.3m0.89% 0.89% UnchangedShares held: Q2 2022 1.2m, Q3 2022 5.4m, Q4 2022 6.7m, Q1 2023 6.7m
27 MACROGENICS INC COM MGNX MGNX 1,703,204 $12.2m0.88% 0.88% NewShares held: Q2 2022 0, Q3 2022 701.6k, Q4 2022 0, Q1 2023 1.7m
28 REPLIMUNE GROUP INC COM REPL REPL 686,762 $12.1m0.88% 0.88% ReducedShares held: Q2 2022 806.3k, Q3 2022 806.3k, Q4 2022 931.6k, Q1 2023 686.8k -244.8k -244,798 -26.3%
29 VECTIVBIO HLDG AG ORD SHS ORD SHS 1,352,199 $11.6m0.84% 0.84% AddedShares held: Q2 2022 0, Q3 2022 0, Q4 2022 1.3m, Q1 2023 1.4m +18.8k +18,799 1.4%
30 CEREVEL THERAPEUTICS HLDNG I COM CERE CERE 393,000 $9.6m0.69% 0.69% UnchangedShares held: Q2 2022 202.3k, Q3 2022 393.0k, Q4 2022 393.0k, Q1 2023 393.0k
31 IMMUNOVANT INC COM IMVT IMVT 585,759 $9.1m0.66% 0.66% UnchangedShares held: Q2 2022 585.8k, Q3 2022 585.8k, Q4 2022 585.8k, Q1 2023 585.8k
32 SUTRO BIOPHARMA INC COM COM 1,776,479 $8.2m0.59% 0.59% UnchangedShares held: Q2 2022 1.8m, Q3 2022 1.8m, Q4 2022 1.8m, Q1 2023 1.8m
33 MORPHIC HLDG INC COM MORF MORF 214,240 $8.1m0.58% 0.58% NewShares held: Q2 2022 0, Q3 2022 0, Q4 2022 0, Q1 2023 214.2k
34 ARVINAS INC COM ARVN ARVN 285,331 $7.8m0.56% 0.56% UnchangedShares held: Q2 2022 285.3k, Q3 2022 285.3k, Q4 2022 285.3k, Q1 2023 285.3k
35 AVIDITY BIOSCIENCES INC COM RNA RNA 500,000 $7.7m0.56% 0.56% UnchangedShares held: Q2 2022 0, Q3 2022 0, Q4 2022 500.0k, Q1 2023 500.0k
36 INTELLIA THERAPEUTICS INC COM NTLA NTLA 203,684 $7.6m0.55% 0.55% UnchangedShares held: Q2 2022 203.7k, Q3 2022 203.7k, Q4 2022 203.7k, Q1 2023 203.7k
37 AUTOLUS THERAPEUTICS PLC SPON ADS AUTL AUTL 3,746,857 $6.9m0.50% 0.50% UnchangedShares held: Q2 2022 3.7m, Q3 2022 3.7m, Q4 2022 3.7m, Q1 2023 3.7m
38 AEROVATE THERAPEUTICS INC COM COM 338,110 $6.8m0.49% 0.49% NewShares held: Q2 2022 0, Q3 2022 0, Q4 2022 0, Q1 2023 338.1k
39 PROTHENA CORP PLC SHS PRTA PRTA 127,900 $6.2m0.45% 0.45% UnchangedShares held: Q2 2022 0, Q3 2022 0, Q4 2022 127.9k, Q1 2023 127.9k
40 ZYMEWORKS INC COM ZYME ZYME 610,000 $5.5m0.40% 0.40% UnchangedShares held: Q2 2022 0, Q3 2022 0, Q4 2022 610.0k, Q1 2023 610.0k
41 SILENCE THERAPEUTICS PLC ADS SLN SLN 881,173 $5.5m0.40% 0.40% UnchangedShares held: Q2 2022 881.2k, Q3 2022 881.2k, Q4 2022 881.2k, Q1 2023 881.2k
42 ALLAKOS INC COM ALLKG ALLKG 1,112,684 $5.0m0.36% 0.36% ReducedShares held: Q2 2022 0, Q3 2022 4.8m, Q4 2022 4.8m, Q1 2023 1.1m -3.7m -3,679,316 -76.8%
43 BLUEBIRD BIO INC COM COM 1,440,757 $4.6m0.33% 0.33% UnchangedShares held: Q2 2022 0, Q3 2022 1.4m, Q4 2022 1.4m, Q1 2023 1.4m
44 EDGEWISE THERAPEUTICS INC COM EWTX EWTX 682,461 $4.6m0.33% 0.33% NewShares held: Q2 2022 0, Q3 2022 0, Q4 2022 0, Q1 2023 682.5k
45 PASSAGE BIO INC COM COM 3,756,915 $3.6m0.26% 0.26% UnchangedShares held: Q2 2022 5.0m, Q3 2022 3.8m, Q4 2022 3.8m, Q1 2023 3.8m
46 ADC THERAPEUTICS SA SHS ADCT ADCT 1,647,030 $3.2m0.23% 0.23% NewShares held: Q2 2022 0, Q3 2022 0, Q4 2022 0, Q1 2023 1.6m
47 ACLARIS THERAPEUTICS INC COM ACRS ACRS 264,377 $2.1m0.15% 0.15% ReducedShares held: Q2 2022 408.3k, Q3 2022 408.3k, Q4 2022 290.2k, Q1 2023 264.4k -25.8k -25,812 -8.9%
48 NEWAMSTERDAM PHARMA COMPANY *W EXP 11/22/202 NAMSW NAMSW 500,333 $920.6k0.07% 0.07% UnchangedShares held: Q2 2022 0, Q3 2022 0, Q4 2022 500.3k, Q1 2023 500.3k
49 NABRIVA THERAPEUTICS PLC SHS NEW 2022 NBRVF NBRVF 17,025 $29.7k0.00% 0.00% UnchangedShares held: Q2 2022 0, Q3 2022 17.0k, Q4 2022 17.0k, Q1 2023 17.0k

Sold out since Q4 2022

SecurityTickerShares held beforeValue then
IMAGO BIOSCIENCES INC 3,987,207 $143.3m4.0m shares
ESSA PHARMA INC EPI EPI 605,141 $1.5m605.1k shares
APTINYX INC 1,883,244 $537.3k1.9m shares